Effectiveness of premix insulin in type 2 diabetes: a retrospective UK cohort study

被引：0
|
作者：
Jude, E. [1 ]
Ali, A. [2 ]
Emral, R. [3 ]
Nanda, N. [4 ]
Lubwama, R. [5 ]
Palmer, K. [6 ]
Shaunik, A. [5 ]
Raskin, P. [7 ]
Gomez Peralta, F. [8 ]
Trescoli, C. [9 ]
机构：
[1] Tameside Hosp NHS Fdn Trust, Ashton Under Lyne, England
[2] Oakenhurst Med Practice, Blackburn, Lancs, England
[3] Ankara Univ, Sch Med, Dept Endocrinol & Metab Dis, Ankara, Turkey
[4] Farnham Rd Practice, Slough, Berks, England
[5] Sanofi, Bridgewater, MA USA
[6] Sanofi, Reading, Berks, England
[7] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA
[8] Segovia Gen Hosp, Endocrinol & Nutr Unit, Segovia, Spain
[9] Hosp Univ La Ribera, Alzira, Spain
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
666
引用
收藏
页码：S321 / S322
页数：2
相关论文
共 50 条
  • [41] Prescribed Total Daily Insulin Dose and Predictors of Insulin Dose for Adults with Type 2 Diabetes on Multiple Daily Injections of Insulin: A Retrospective Cohort Study
    Wright, Eugene E., Jr.
    Shah, Viral N.
    Miller, Eden
    Thach, Andrew
    Javadi, Pasha
    Davies, Shawn
    Sieradzan, Ray
    DIABETOLOGY, 2025, 6 (02):
  • [42] Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
    Perez-Nieves, Magaly
    Boye, Kristina S.
    Kiljanski, Jacek
    Cao, Dachung
    Lage, Maureen J.
    DIABETES THERAPY, 2018, 9 (03) : 1099 - 1111
  • [43] The management of people with Type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study
    Calvert, M. J.
    McManus, R. J.
    Freemantle, N.
    DIABETIC MEDICINE, 2007, 24 : 43 - 43
  • [44] Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
    Magaly Perez-Nieves
    Kristina S. Boye
    Jacek Kiljanski
    Dachung Cao
    Maureen J. Lage
    Diabetes Therapy, 2018, 9 : 1099 - 1111
  • [45] Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)
    Berra, Cesare C.
    Rossi, Maria Chiara
    Mirani, Marco
    Ceccarelli Ceccarelli, Daniela
    Romano, Cristina
    Sassi, Lorenza
    Peretti, Elena
    Favacchio, Giuseppe
    Pastore, Ida
    Folini, Laura
    Graziano, Giusi
    Lunati, Maria Elena
    Solerte, Sebastiano Bruno
    Fiorina, Paolo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [46] Safety and effectiveness of insulin detemir in type 2 diabetes: Results from the ASEAN cohort of the A1chieve study
    Soewondo, Pradana
    Mohamed, Mafauzy
    Jain, Anand B.
    Sy, Rosa Allyn G.
    Khoo, Chin Meng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S10 - S16
  • [47] Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes
    Ted Wu
    Bryan Betty
    Michelle Downie
    Manish Khanolkar
    Gary Kilov
    Brandon Orr-Walker
    Gordon Senator
    Greg Fulcher
    Diabetes Therapy, 2015, 6 : 273 - 287
  • [48] Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009-2018: a retrospective cohort study
    Pal, Kingshuk
    Horsfall, Laura
    Sharma, Manuj
    Nazareth, Irwin
    Petersen, Irene
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [49] Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US
    Hui Shao
    Abdul Jabbar Omar Alsaleh
    Terry Dex
    Elisheva Lew
    Vivian Fonseca
    Diabetes Therapy, 2022, 13 : 1659 - 1670
  • [50] Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US
    Shao, Hui
    Alsaleh, Abdul Jabbar Omar
    Dex, Terry
    Lew, Elisheva
    Fonseca, Vivian
    DIABETES THERAPY, 2022, 13 (09) : 1659 - 1670
12345